KW-2478

· Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KW-2478, covering 2014-11-05 to 2024-04-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma [Phase 1]

See pricing